OKYO Pharma Limited (OKYO)

NASDAQ: OKYO · IEX Real-Time Price · USD
0.00 (0.00%)
At close: Aug 5, 2022 4:00 PM
+0.07 (3.07%)
After-hours: Aug 8, 2022 6:32 PM EDT

Total Valuation

OKYO Pharma has a market cap or net worth of $46.15 million. The enterprise value is $41.05 million.

Market Cap 46.15M
Enterprise Value 41.05M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

OKYO Pharma has 21.77 million shares outstanding.

Shares Outstanding 21.77M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.06%
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 9.31
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.95, with a Debt / Equity ratio of 0.02.

Current Ratio 8.95
Quick Ratio 8.61
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$879,120
Employee Count 6
Asset Turnover n/a
Inventory Turnover n/a


Income Tax -213,842
Effective Tax Rate n/a

Stock Price Statistics

Beta (1Y) 0.23
Total Price Change -45.38%
50-Day Moving Average 2.12
200-Day Moving Average 2.19
Average Volume (30 Days) 110,807

Short Selling Information

The latest short interest is 100, so 0.00% of the outstanding shares have been sold short.

Short Interest 100
Short % of Shares Out 0.00%
Short % of Float n/a
Short Ratio (days to cover) 0.00

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -5.54M
Pretax Income -5.49M
Net Income -5.27M
EBIT -5.49M
Earnings Per Share (EPS) -$0.24
Full Income Statement

Balance Sheet

The company has $5.18 million in cash and $81,781 in debt, giving a net cash position of $5.10 million or $0.23 per share.

Cash & Cash Equivalents 5.18M
Total Debt 81,781
Net Cash 5.10M
Net Cash Per Share $0.23
Book Value 4.96M
Book Value Per Share 0.23
Working Capital 4.92M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$4.09 million and capital expenditures -$5,015, giving a free cash flow of -$4.10 million.

Operating Cash Flow -4.09M
Capital Expenditures -5,015
Free Cash Flow -4.10M
FCF Per Share n/a
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

OKYO Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -11.43%
FCF Yield -8.88%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a